Research · Sep 3, 2026
BHC: FY25 Deep Dive
Bausch Health FY25 at $10.31B. NI $155M; EPS $0.41.
BHC
Bausch Health Companies Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$6.56
−2.96%NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · CA
Research · Sep 3, 2026
Bausch Health FY25 at $10.31B. NI $155M; EPS $0.41.